期刊文献+

HPV分型与HPVL1蛋白联合检测在判断宫颈疾病预后中的意义 被引量:5

Significance of HPV DNA Type Combined with HPV L1 Capsid Protein Detection in the Prognosis of Cervical Lesions
下载PDF
导出
摘要 目的:分析人乳头瘤病毒(HPV)分型与HPV L1蛋白联合检测在判断宫颈疾病预后中的临床意义。方法:选择2011年1月—2012年7月在皖南医学院第一附属医院妇科门诊检测HPV分型高危型阳性,液基薄层细胞学(TCT)检查≥未明确诊断意义的不典型鳞状上皮细胞(ASCUS),最后经组织病理确诊的114例患者作为研究对象,用免疫组化法检测HPV L1蛋白的表达情况,分析HPV亚型、L1蛋白及病理结果之间的关系。结果:在炎症、宫颈上皮内瘤变Ⅰ(CINⅠ)、CINⅡ/Ⅲ和鳞状细胞癌(SCC)中,HPV L1蛋白阳性率分别为64.3%(27/42)、54.5%(6/11)、15.7%(8/51)、0(0/10),HPV L1蛋白阳性率随着宫颈上皮病变加重而逐渐降低(P<0.05)。在114例患者中,HPV16感染阳性最多,占50%(57/114),其次分别为52型(14.91%)、58型(14.04%)、18型(7.89%)。HPV L1蛋白在HPV16和18亚型中呈低表达,在52、58亚型中呈高表达,且在感染HPV52、58亚型患者中L1蛋白阳性组中炎症所占的比例明显高于L1蛋白阴性组中的比例,差异有统计学意义(P<0.05)。结论:HPV L1蛋白的检测有助于判断宫颈疾病的程度及恶性进展趋势,联合HPV分型检测对其预后和处理有一定的指导意义。 Objective:To analyze the relationship between the two methods and pathological results. Methods:Totally 114 patients who had the results of positive high-risk HPV,pathology and thin-prep liquid-based cytology(TCT) test diagnosed of a typical squamous cells of undetermined significance (ASCUS) and above in the First Affiliated Hospital of Wannan Medical College gynecology clinic from January 2011 to July 2012 were analyzed retrospectively. The expression of HPV L1 were detected in cervical lesions. We analyze the relationship between the subtypes of HPV ,HPV L1 capsid protein and pathological results. Results:The positive expression rate of HPV L1 was 64.3%(27/42),54.5%(6/11),15.7%(8/51),0(0/10) in cervictis, CINⅠ,CINⅡ/Ⅲ,SCC,HPV L1 capsid protein expression gradually decreased with cervical lesions increased. The most common HPV subtypes among the 114 patients were HPV16 (50%),HPV52 (14.91%),HPV58 (14.04%),HPV18 (7.89%), respectively. In the single infection 16 and 18 subtypes of HPV, HPV L1 protein negative rate in L1 protein rate was low expression,but highly expression in 52,58 subtypes. And in cervical tissue infected with HPV52 and HPV58, HPV L1 protein positive expression group finally confirmed by pathology of inflammation was significantly higher than that of negative group (P〉0.05). Conclusions:The HPV L1 testing is useful in evaluation of cervical lesions and progression risk of cervical dysplasia ,the combination of both HPV L1 and HPV DNA detection can be helpful in management and prognostic prediction.
出处 《国际妇产科学杂志》 CAS 2014年第6期667-669,I0001,共4页 Journal of International Obstetrics and Gynecology
基金 芜湖市2009年度农社类科技计划项目(卫生类-2-2)
关键词 乳头状瘤病毒科 人乳头瘤病毒16 宫颈疾病 免疫组织化学 Papillomaviridae Uterine cervical diseases Immunohistochemistry
  • 相关文献

参考文献8

  • 1Parkin DM,Bray F,Ferlay J,et al. Estimating the world cancerburden: Globacan 2000[J]. Int J cancer, 2001,94(2) : 153-156.
  • 2Rauber D,Mehlhom G,Fasching PA,et al. Prognostic significance ofthe detection of human papillomavirus LI proteininsm ears of mildto moderate cervical in traepitheliallesions [J]. Eur J Obstet GynecolReprod Biol,2008,140(2) :258-262.
  • 3Yu L,Wang L,Zhong J,et al. Diagnostic value of pl6INK4A,Ki-67,and human papillomavirus LI capsid protein immumochemicalstaining on cell blocks from residual liquid -based gynecologiccytology specimens[J]. CancerCytopathol,2010,118( 1):47-55.
  • 4肖巍,卞美璐,马莉,刘军,陈颖.子宫颈液基细胞学检查异常的涂片中人乳头状瘤病毒L1蛋白的表达及其意义[J].中华妇产科杂志,2009,44(12):887-891. 被引量:29
  • 5Melshemier P,Kaul S,Dobeck S,et al. Immunocytochemical detection ofHPV high-risk type LI capsid proteins in LSIL and HSIL as con^>aredwith detection of HPV LI DNA[J]. Acta Cytol,2003,47(2) : 124-128.
  • 6Griesser H,Sander H,Hilfrich R,et al. Correlation of imunochemicaldetection of HPV LI capsid protein in pap smears with regression ofhigh-risk HPV positive mild/moderate dysplasia [J]. Anal Quant CytolHistol,2004,26(5): 241-245.
  • 7张佳立,郜红艺,张江宇,吴坤河,郭玉娟,李辉斌.宫颈液基细胞HPV L1壳蛋白表达的临床意义[J].诊断病理学杂志,2010,17(6):456-459. 被引量:13
  • 8史健,邓宽国,刘玉霞,尹石华.人乳头状瘤病毒及其L1蛋白检测在宫颈病变诊断中的应用[J].医学检验与临床,2010(6):70-72. 被引量:2

二级参考文献33

  • 1郜红艺,张佳立,张江宇,吴坤河,梁驹卿,潘小英,张畅斌.人乳头瘤病毒感染者宫颈组织病理学研究[J].热带医学杂志,2006,6(7):768-772. 被引量:12
  • 2Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA, 1999, 281 : 1605- 1610.
  • 3Siddiqui MT, Hornaman K, Cohen C, et al. ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASCUS) cytology: correlation study with histologic biopsy. Arch Pathol Lab Med, 2008, 132 : 1648-1652.
  • 4Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev, 2003, 16:1-17.
  • 5Doorbar J. The papillomavirus life cycle. J Clin Virol, 2005, 32 Suppl 1 :S7-15.
  • 6Yoshida T, Sano T, Kanuma T, et al. Immunochemical analysis of HPV LI capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions. Cancer, 2008, 114:83-88.
  • 7Evander M, Edlund K, Gustafsson A, et al. Human papillomavirus infection is transient in young women : a population-based cohort study. J Infect Dis, 1995, 171:1026-1030.
  • 8Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst, 2000, 9:464-474.
  • 9Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 1998, 338:423-428.
  • 10Stanley M. Immune responses to human papillomavirus. Vaccine, 2006, 24 Suppl 1 :S16-22.

共引文献37

同被引文献38

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部